Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ALT
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

33.13

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.06

EPS Last/This Y

EPS This/Next Y

-0.33

Price

6.42

Target Price

21.71

Analyst Recom

1.25

Performance Q

-10.07

Relative Volume

0.63

Beta

0.84

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-01-23ALT7.070.210.42105203
2025-01-24ALT6.970.220.16107682
2025-01-27ALT70.230.24103576
2025-01-28ALT6.920.230.31107240
2025-01-29ALT6.940.240.54108821
2025-01-30ALT70.240.43112047
2025-01-31ALT6.630.250.17113316
2025-02-03ALT6.430.250.31107452
2025-02-04ALT6.640.260.15111477
2025-02-05ALT6.990.250.13112541
2025-02-06ALT6.910.250.13115576
2025-02-07ALT6.660.250.11118548
2025-02-10ALT6.630.241.46111540
2025-02-11ALT6.290.270.09116332
2025-02-12ALT6.230.260.33120789
2025-02-13ALT6.240.260.08121723
2025-02-14ALT6.380.270.19120559
2025-02-18ALT6.480.250.24116938
2025-02-19ALT6.780.250.52119712
2025-02-20ALT6.630.261.40124639
2025-02-21ALT6.420.290.34132554
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-01-23ALT7.06173.0-38.7-0.80
2025-01-24ALT6.98173.0-33.4-0.80
2025-01-27ALT7.00173.0-36.0-0.80
2025-01-28ALT6.93173.0-33.2-0.80
2025-01-29ALT6.94173.0-35.6-0.80
2025-01-30ALT7.00173.0-36.9-0.80
2025-01-31ALT6.63173.0-25.2-0.80
2025-02-03ALT6.44-1.9-29.6-0.80
2025-02-04ALT6.64-1.9-41.8-0.80
2025-02-05ALT6.99-1.9-46.2-0.80
2025-02-06ALT6.91-1.9-33.4-0.80
2025-02-07ALT6.66-1.9-28.5-0.80
2025-02-10ALT6.61-1.9-33.9-0.80
2025-02-11ALT6.29-1.9-26.1-0.80
2025-02-12ALT6.23-1.9-33.6-0.80
2025-02-13ALT6.24-1.9-36.1-0.80
2025-02-14ALT6.37-1.9-40.2-0.80
2025-02-18ALT6.47-1.9-38.9-0.80
2025-02-19ALT6.78-1.9-44.4-0.80
2025-02-20ALT6.62-1.9-31.0-0.80
2025-02-21ALT6.42-1.9-29.2-0.80
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-01-23ALT-2.61-6.5933.59
2025-01-24ALT-2.61-6.5933.59
2025-01-27ALT-2.61-6.4633.59
2025-01-28ALT-2.61-6.4634.87
2025-01-29ALT-2.61-6.4634.87
2025-01-30ALT-2.61-6.4634.87
2025-01-31ALT-2.61-6.4634.87
2025-02-03ALT-2.61-6.5434.90
2025-02-04ALT-2.39-6.5434.90
2025-02-05ALT-2.39-6.5434.90
2025-02-06ALT-2.39-6.5434.90
2025-02-07ALT-2.14-6.5434.94
2025-02-10ALT-2.14-6.4134.94
2025-02-11ALT-2.12-6.4134.94
2025-02-12ALT-2.12-6.4133.13
2025-02-13ALT-2.12-6.4133.13
2025-02-14ALT-2.10-6.4133.13
2025-02-18ALT-2.10-5.8133.16
2025-02-19ALT-1.95-5.8133.16
2025-02-20ALT-1.95-5.8133.16
2025-02-21ALT0.00-5.8133.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.32

Avg. EPS Est. Current Quarter

0.24

Avg. EPS Est. Next Quarter

-0.38

Insider Transactions

Institutional Transactions

-5.81

Beta

0.84

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

34

Sentiment Score

80

Actual DrawDown %

81.7

Max Drawdown 5-Year %

-93.6

Target Price

21.71

P/E

Forward P/E

PEG

P/S

9146.7

P/B

3.43

P/Free Cash Flow

EPS

-1.55

Average EPS Est. Cur. Y​

-0.8

EPS Next Y. (Est.)

-1.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-199076.92

Relative Volume

0.63

Return on Equity vs Sector %

-96.9

Return on Equity vs Industry %

-81.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-29.2
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

Altimmune, Inc.
ALT
$6.43
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $457,331,168.00
EPSttm : -1.57
finviz dynamic chart for ALT
Altimmune, Inc.
$6.43
3.02%
$0.2

Float Short %

33.13

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.06

EPS Last/This Y

EPS This/Next Y

-0.33

Price

6.42

Target Price

21.71

Analyst Recom

1.25

Performance Q

-10.07

Relative Volume

0.63

Beta

0.84

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-01-23ALT7.070.210.42105203
2025-01-24ALT6.970.220.16107682
2025-01-27ALT70.230.24103576
2025-01-28ALT6.920.230.31107240
2025-01-29ALT6.940.240.54108821
2025-01-30ALT70.240.43112047
2025-01-31ALT6.630.250.17113316
2025-02-03ALT6.430.250.31107452
2025-02-04ALT6.640.260.15111477
2025-02-05ALT6.990.250.13112541
2025-02-06ALT6.910.250.13115576
2025-02-07ALT6.660.250.11118548
2025-02-10ALT6.630.241.46111540
2025-02-11ALT6.290.270.09116332
2025-02-12ALT6.230.260.33120789
2025-02-13ALT6.240.260.08121723
2025-02-14ALT6.380.270.19120559
2025-02-18ALT6.480.250.24116938
2025-02-19ALT6.780.250.52119712
2025-02-20ALT6.630.261.40124639
2025-02-21ALT6.420.290.34132554
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-01-23ALT7.06173.0-38.7-0.80
2025-01-24ALT6.98173.0-33.4-0.80
2025-01-27ALT7.00173.0-36.0-0.80
2025-01-28ALT6.93173.0-33.2-0.80
2025-01-29ALT6.94173.0-35.6-0.80
2025-01-30ALT7.00173.0-36.9-0.80
2025-01-31ALT6.63173.0-25.2-0.80
2025-02-03ALT6.44-1.9-29.6-0.80
2025-02-04ALT6.64-1.9-41.8-0.80
2025-02-05ALT6.99-1.9-46.2-0.80
2025-02-06ALT6.91-1.9-33.4-0.80
2025-02-07ALT6.66-1.9-28.5-0.80
2025-02-10ALT6.61-1.9-33.9-0.80
2025-02-11ALT6.29-1.9-26.1-0.80
2025-02-12ALT6.23-1.9-33.6-0.80
2025-02-13ALT6.24-1.9-36.1-0.80
2025-02-14ALT6.37-1.9-40.2-0.80
2025-02-18ALT6.47-1.9-38.9-0.80
2025-02-19ALT6.78-1.9-44.4-0.80
2025-02-20ALT6.62-1.9-31.0-0.80
2025-02-21ALT6.42-1.9-29.2-0.80
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-01-23ALT-2.61-6.5933.59
2025-01-24ALT-2.61-6.5933.59
2025-01-27ALT-2.61-6.4633.59
2025-01-28ALT-2.61-6.4634.87
2025-01-29ALT-2.61-6.4634.87
2025-01-30ALT-2.61-6.4634.87
2025-01-31ALT-2.61-6.4634.87
2025-02-03ALT-2.61-6.5434.90
2025-02-04ALT-2.39-6.5434.90
2025-02-05ALT-2.39-6.5434.90
2025-02-06ALT-2.39-6.5434.90
2025-02-07ALT-2.14-6.5434.94
2025-02-10ALT-2.14-6.4134.94
2025-02-11ALT-2.12-6.4134.94
2025-02-12ALT-2.12-6.4133.13
2025-02-13ALT-2.12-6.4133.13
2025-02-14ALT-2.10-6.4133.13
2025-02-18ALT-2.10-5.8133.16
2025-02-19ALT-1.95-5.8133.16
2025-02-20ALT-1.95-5.8133.16
2025-02-21ALT0.00-5.8133.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.32

Avg. EPS Est. Current Quarter

0.24

Avg. EPS Est. Next Quarter

-0.38

Insider Transactions

Institutional Transactions

-5.81

Beta

0.84

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

34

Sentiment Score

80

Actual DrawDown %

81.7

Max Drawdown 5-Year %

-93.6

Target Price

21.71

P/E

Forward P/E

PEG

P/S

9146.7

P/B

3.43

P/Free Cash Flow

EPS

-1.55

Average EPS Est. Cur. Y​

-0.8

EPS Next Y. (Est.)

-1.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-199076.92

Relative Volume

0.63

Return on Equity vs Sector %

-96.9

Return on Equity vs Industry %

-81.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-29.2
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading